
What is the 17p deletion?
In this week’s episode of #AskDrDurie Dr. Brian G.M. Durie discusses the importance of the 17p deletion chromosome abnormality when remission has been achieved.
If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].
To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.
Previous Post
IMWG 2014: Imaging
Next Post
If bone density is low, does that mean myeloma is present?